CrossRef Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitusa study protocol Noor Suleiman, Meis Alkasem, Zaina Al Amer, Obada Salameh, Noora Al-Thani, Mohammad Khair Hamad, Khaled Baagar, Ibrahem Abdalhakam, Manal Othman, Ragae Dughmosh, Dabia Al-Mohanadi, Ali Al Sanousi, Mohammed Bashir, Odette Chagoury, Shahrad Taheri, Abdul-Ba Trials.2022;[Epub] CrossRef Digital environment: An evolutionary component in environmental health Afiqah Syamimi Masrani, Nik Rosmawati Nik Husain Journal of Public Health Research.2022;[Epub] CrossRef Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic Lavanya Kondapalli, Garima Arora, Riem Hawi, Efstathia Andrikopoulou, Courtney Estes, Nirav Patel, Carrie G
Consult with a healthcare professional for personalized guidance
About Diabetes Approximately 34 million Americans1 (just over 1 in 10) and an estimated 463 million adults worldwide2 have diabetes
Three hundred dollars a month
Presented for research literature review only Gilad E et al
| Are Research Peptides Legal